Comparative cardiovascular safety of insulin secretagogues following hospitalization for ischemic heart disease among type 2 diabetes patients: A cohort study

Journal of Diabetes and its Complications

Volumn 29, Issue 2, 2015, Pages 196-202

  Huang, Yuhao ^a   Abdelmoneim, Ahmed S ^b   Light, Peter ^a   Qiu, Weiyu ^b   Simpson, Scot H ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Atrial fibrillation; Insulin secretagogue; Ischemic heart disease; Retrospective cohort study; Type 2 diabetes

Indexed keywords

GLIBENCLAMIDE; GLICLAZIDE; REPAGLINIDE; ANTIDIABETIC AGENT; CARBAMIC ACID DERIVATIVE; PIPERIDINE DERIVATIVE;

AGED; ARTICLE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMPARATIVE STUDY; DIABETIC PATIENT; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; ALBERTA; BLUE CROSS BLUE SHIELD; CARDIOVASCULAR DISEASES; CHEMICALLY INDUCED; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC CARDIOMYOPATHIES; FACTUAL DATABASE; INSURANCE; MORTALITY; MYOCARDIAL ISCHEMIA; PROPORTIONAL HAZARDS MODEL; RISK; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALBERTA; BLUE CROSS BLUE SHIELD INSURANCE PLANS; CARBAMATES; CARDIOVASCULAR DISEASES; COHORT STUDIES; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC CARDIOMYOPATHIES; FEMALE; GLICLAZIDE; GLYBURIDE; HOSPITALIZATION; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MYOCARDIAL ISCHEMIA; PIPERIDINES; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK; UNIVERSAL COVERAGE;

EID: 84923107657     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2014.11.012     Document Type: Article

References (44)

1. A.S. Abdelmoneim, D.T. Eurich, J.M. Gamble, J.A. Johnson, J.M. Seubert, and W. Qiu Risk of acute coronary events associated with glyburide compared with gliclazide use in patients with type 2 diabetes: A nested case-control study Diabetes, Obesity & Metabolism 16 2014 22 29
2. A.S. Abdelmoneim, S.E. Hasenbank, J.M. Seubert, D.R. Brocks, P.E. Light, and S.H. Simpson Variations in tissue selectivity amongst insulin secretagogues: A systematic review Diabetes, Obesity & Metabolism 14 2012 130 138
3. A.M. Arruda-Olson, R.K. Patch, C.L. Leibson, A. Vella, R.L. Frye, and S.A. Weston Effect of second-generation sulfonylureas on survival in patients with diabetes mellitus after myocardial infarction Mayo Clinic Proceedings 84 2009 28 33
4. F.M. Ashcroft, and P. Rorsman Electrophysiology of the pancreatic beta-cell Progress in Biophysics and Molecular Biology 54 1989 87 143
5. I. Baczkó, Z. Husti, V. Lang, I. Leprán, and P.E. Light Sarcolemmal KATP channel modulators and cardiac arrhythmias Current Medicinal Chemistry 18 2011 3640 3661
6. Committee CDACPGE Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada Canadian Journal of Diabetes 32 2008
7. J. Cramer A systematic review of adherence with medications for diabetes Diabetes Care 27 2004 1218 1224
8. R. Dehejia, and S. Wahba Propensity score-matching methods for nonexperimental causal studies The Review of Economics and Statistics 84 2002 151 161
9. C. Desouza, H. Salazar, B. Cheong, J. Murgo, and V. Fonseca Association of hypoglycemia and cardiac ischemia: A study based on continuous monitoring Diabetes Care 26 2003 1485 1489
10. A. Elixhauser, C. Steiner, D. Harris, and R. Coffey Comorbidity measures for use with administrative data Medical Care 36 1998 8 27
11. T. Forst, M. Hanefeld, S. Jacob, G. Moeser, G. Schwenk, and A. Pfutzner Association of sulphonylurea treatment with all-cause and cardiovascular mortality: A systematic review and meta-analysis of observational studies Diabetes & vascular disease research: official journal of the International Society of Diabetes and Vascular Disease 10 2013 302 314
12. T. Furukawa, S. Kimura, N. Furukawa, A.L. Bassett, and R.J. Myerburg Role of cardiac ATP-regulated potassium channels in differential responses of endocardial and epicardial cells to ischemia Circulation Research 68 1991 1693 1702
13. J.-M. Gamble, D.T. Eurich, J.A. Ezekowitz, P. Kaul, H. Quan, and F.A. McAlister Patterns of care and outcomes differ for urban versus rural patients with newly diagnosed heart failure, even in a universal healthcare system Circulation. Heart Failure 4 2011 317 323
14. A.S. Gangji, T. Cukierman, H.C. Gerstein, C.H. Goldsmith, and C.M. Clase A systematic review and meta-analysis of hypoglycemia and cardiovascular events: A comparison of glyburide with other secretagogues and with insulin Diabetes Care 30 2007 389 394
15. A.V. Ghuran, and A.J. Camm Ischaemic heart disease presenting as arrhythmias British Medical Bulletin 59 2001 193 210
16. F.M. Gribble, and F. Reimann Sulphonylurea action revisited: The post-cloning era Diabetologia 46 2003 875 891
17. J. Gromada, S. Dissing, H. Kofod, and J. Frøkjaer-Jensen Effects of the hypoglycemic drugs repaglinide and glibenclamide on ATP-sensitive potassium channels and cytosolic calcium levels in B TC3 cells and rat pancreatic beta cells Diabetologia 38 1995 1025 1032
18. H. Horsdal, S. Johnsen, F. Sondergaard, J. Jacobsen, R. Thomsen, and O. Schmitz Sulfonylureas and prognosis after myocardial infarction in patients with diabetes: A populationbased followup study Diabetes/Metabolism Research and Reviews 25 2009 515 522
19. H.T. Horsdal, S.P. Johnsen, F. Søndergaard, and J. Rungby Type of preadmission glucose-lowering treatment and prognosis among patients hospitalised with myocardial infarction: A nationwide follow-up study Diabetologia 51 2008 567 574
20. P.N. Jensen, K. Johnson, J. Floyd, S.R. Heckbert, R. Carnahan, and S. Dublin A systematic review of validated methods for identifying atrial fibrillation using administrative data Pharmacoepidemiology and Drug Safety 21 S1 2012 141 147
21. C.H. Jørgensen, G.H. Gislason, C. Andersson, O. Ahlehoff, M. Charlot, and T.K. Schramm Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention-A retrospective nationwide cohort study Cardiovascular Diabetology 9 2010 54
22. C.H. Jørgensen, G.H. Gislason, D. Bretler, R. Sørensen, M.L. Norgaard, and M.L. Hansen Glyburide increases risk in patients with diabetes mellitus after emergent percutaneous intervention for myocardial infarction - A nationwide study Int J Cardiol 152 2011 Elsevier Ireland Ltd 327 331
23. D.N. Juurlink, T. Gomes, B.R. Shah, and M.M. Mamdani Adverse cardiovascular events during treatment with glyburide (glibenclamide) or gliclazide in a high-risk population Diabetic Medicine 29 2012 1524 1528
24. P.F. Kantor, W.A. Coetzee, E.E. Carmeliet, S.C. Dennis, and L.H. Opie Reduction of ischemic K + loss and arrhythmias in rat hearts. Effect of glibenclamide, a sulfonylurea Circulation Research 66 1990 478 485
25. S.-J. Kim, H. Zhang, I. Khaliulin, S.C.M. Choisy, R. Bond, and H. Lin Activation of glibenclamide-sensitive ATP-sensitive K + channels during β-adrenergically induced metabolic stress produces a substrate for atrial tachyarrhythmia Circulation. Arrhythmia and electrophysiology 5 2012 1184 1192
26. S.B. Kristiansen, B. Løfgren, J.M. Nielsen, N.B. Støttrup, E.S. Buhl, and J.E. Nielsen-Kudsk Comparison of two sulfonylureas with high and low myocardial K(ATP) channel affinity on myocardial infarct size and metabolism in a rat model of type 2 diabetes Diabetologia 54 2011 451 458
27. L. Landstedt-Hallin, A. Englund, U. Adamson, and P.E. Lins Increased QT dispersion during hypoglycaemia in patients with type 2 diabetes mellitus Journal of Internal Medicine 246 1999 299 307
28. V. Lang, and P.E. Light The molecular mechanisms and pharmacotherapy of ATP-sensitive potassium channel gene mutations underlying neonatal diabetes Pharmacogenomics and personalized medicine 3 2010 145 161
29. D.S. Lee, A. Stitt, X. Wang, J.S. Yu, Y. Gurevich, and K.J. Kingsbury Administrative hospitalization database validation of cardiac procedure codes Medical Care 51 2013 22 26
30. B. Li, D. Evans, P. Faris, S. Dean, and H. Quan Risk adjustment performance of Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 administrative databases BMC Health Services Research 8 2008 12
31. S.R. Majumdar, B.R. Hemmelgarn, M. Lin, K. McBrien, B.J. Manns, and M. Tonelli Hypoglycemia associated with hospitalization and adverse events in older people: Population-based cohort study Diabetes Care 36 2013 3585 3590
32. M. Monami, C. Nardini, and E. Mannucci Efficacy and safety of sodium glucose co-transport-2 inhibitors in type 2 diabetes: A meta-analysis of randomized clinical trials Diabetes, Obesity & Metabolism 16 2014 457 466
33. J. Nagendran, G.Y. Oudit, J.A. Bakal, P.E. Light, J.R.B. Dyck, and F.A. McAlister Are users of sulphonylureas at the time of an acute coronary syndrome at risk of poorer outcomes? Diabetes, Obesity & Metabolism 15 2013 1022 1028
34. K. Pantalone, M. Kattan, C. Yu, B. Wells, S. Arrigain, and A. Jain The risk of overall mortality in patients with type 2 diabetes receiving glipizide, Glyburide, or glimepiride monotherapy Diabetes Care 33 2010 1224 1229
35. O.D. Pedersen, H. Bagger, L. Køber, and C. Torp-pedersen The occurrence and prognostic significance of atrial fibrillation/-flutter following acute myocardial infarction European Heart Journal 20 1999 748 754
36. O. Phung, D. Sobieraj, S. Engel, and S. Rajpathak Early combination therapy for the treatment of type 2 diabetes mellitus: Systematic review and metaanalysis Diabetes, Obesity & Metabolism 2013 1 8
37. H. Quan, B. Li, L. Duncan Saunders, G.A. Parsons, C.I. Nilsson, and A. Alibhai Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database Health Services Research 43 4 2008 1424 1441
38. H. Quan, V. Sundararajan, P. Halfon, A. Fong, B. Burnand, and J. Luthi Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data Medical Care 43 2005 1130 1139
39. J. Riveline, N. Danchin, F. Ledru, M. Varroud-Vial, and G. Charpentier Sulfonylureas and cardiovascular effects: From experimental data to clinical use. Available data in humans and clinical applications Diabetes & Metabolism 29 2003 207 222
40. S. Schneeweiss, J.A. Rassen, R.J. Glynn, J. Avorn, H. Mogun, and M.A. Brookhart High-dimensional propensity score adjustment in studies of treatment effects using health care claims data Epidemiology 20 2009 512 522
41. L. So, D. Evans, and H. Quan ICD-10 coding algorithms for defining comorbidities of acute myocardial infarction BMC Health Services Research 6 2006 161
42. S. Suissa Immortal time bias in pharmaco-epidemiology American Journal of Epidemiology 167 2008 492 499
43. X. Tang, H. Sato, S. Tiwari, B. Dawn, Q. Bi, and Q. Li Cardioprotection by postconditioning in conscious rats is limited to coronary occlusions < 45 min American journal of physiology. Heart and circulatory physiology 291 2006 2308 2317
44. C. Varas-lorenzo, J. Castellsague, M.R. Stang, L. Tomas, J.A. Bs, and S. Perez-gutthann Positive predictive value of ICD9 codes 410 and 411 in the identification of cases of acute coronary syndromes in the Saskatchewan Hospital automated database Pharmacoepidemiology and Drug Safety 17 2008 842 852